Dicot Pharma AB (publ)

kr 0.21As of Sun 8 Nov 2026, 12:00 UTC
STO:DICOTHealthcare
Country Sweden
PE (Fwd) •••
TSR 8Y CAGR (36.16%)
Div yield —
ROE (46.95%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.82
PE TTM —
TSR TTM (60.41%)
Mkt cap kr 733.3M
ROIC (30.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.267
26.21%
24.25%
Hold 4|10|3|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
7.54%
14.58%
21.27%
9.34%
Revenuekr M
37.57
39.38
41.56
43.22
7.29%
8.22%
12.20%
11.60%
Peers (US$74.13M)
Cap (US$)
PE
77.47M
731.9x
74.06M
14.35x
Capital
TTM
5Y
10Y
Leveragex
6.702
(0.129)
(0.140)
EBIT/Intx
0.994
0.386
0.370
Own earn%
(29.39)
(44.35)
(43.30)
Sh yield%
37.21
51.02
50.88
Owners
Insiders/Inst%
0.72
20.33
Short interest%
4.19
SBC / revenue%
2.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
22–32
$1 testx
—
Incr. ROIC%
2